Molecular Biology Reports

, Volume 40, Issue 1, pp 605–616 | Cite as

Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro

  • Haibo Tang
  • Linhu Ge
  • Wenlong Shao
  • Yuan Qiu
  • Dong Cui


In our present study, we took advantage of the characteristics of RNA interference technology, which can efficiently, stably, and specifically silence target genes, and designed a small interfering RNA (siRNA) that could specifically target hTERT mRNA. We used a lentiviral vector (LV) to deliver the hTERT siRNA into telomerase-positive A549 lung cancer cells and investigated the effect of hTERT siRNA on the hTERT mRNA levels, hTERT protein levels, cell proliferation, and apoptosis in the lung cancer cells. The results from quantitative PCR, Western blotting, and the MTT assay showed that the expression levels of both hTERT mRNA and protein in the cells were significantly decreased and that the cell proliferation rate started to significantly slow down at 48 h after transfection with hTERT-LV. Our study demonstrated that siRNA sequences specifically targeting hTERT mRNA, which were packaged into lentivirus particles and then used to transfect the lung cancer cell line A549, can specifically silence the mRNA of the target gene, hTERT, and then reduce the hTERT protein expression level, which, in turn, reduces cell proliferation, inhibits cell growth, and induces apoptosis.


Lung cancer RNA interference Small interfering RNA Apoptosis 


Conflict of interest

The authors declare no conflicts of interest.


  1. 1.
    Ellis PM, Vandermeer R (2011) Delays in the diagnosis of lung cancer. J Thorac Dis 3(3):183–188PubMedGoogle Scholar
  2. 2.
    Méndez M, Custodio A, Provencio M (2011) New molecular targeted therapies for advanced non-small-cell lung cancer. J Thorac Dis 3(1):30–56PubMedGoogle Scholar
  3. 3.
    Winter H, van den Engel NK, Rusan M, Schupp N, Poehlein CH, Hu HM, Hatz RA, Urba WJ, Jauch KW, Fox BA, Rüttinger D (2011) Active-specific immunotherapy for non-small cell lung cancer. J Thorac Dis 3(2):105–114PubMedGoogle Scholar
  4. 4.
    Hennon MW, Demmy TL (2012) Video-assisted thoracoscopic surgery (VATS) for locally advanced lung cancer. Ann Cardiothorac Surg 1(1):37–42Google Scholar
  5. 5.
    Podlevsky JD, Chen JJ (2012) It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat Res 730(1–2):3–11PubMedGoogle Scholar
  6. 6.
    Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J et al (1995) The RNA component of human telomerase. Science 269(5228):1236–1241PubMedCrossRefGoogle Scholar
  7. 7.
    Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO (1997) A mammalian telomerase-associated protein. Science 275(5302):973–977PubMedCrossRefGoogle Scholar
  8. 8.
    Lingner J, Cech TR (1996) Purification of telomerase from Euplotes aediculatus: requirement of a primer 3′ overhang. Proc Natl Acad Sci USA 93(20):10712–10717PubMedCrossRefGoogle Scholar
  9. 9.
    Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V (1996) Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144(4):1399–1412PubMedGoogle Scholar
  10. 10.
    Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276(5312):561–567PubMedCrossRefGoogle Scholar
  11. 11.
    Counter CM, Meyerson M, Eaton EN, Weinberg RA (1997) The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 94(17):9202–9207PubMedCrossRefGoogle Scholar
  12. 12.
    Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90(4):785–795PubMedCrossRefGoogle Scholar
  13. 13.
    Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17(4):498–502PubMedCrossRefGoogle Scholar
  14. 14.
    Beattie TL, Zhou W, Robinson MO, Harrington L (1998) Reconstitution of human telomerase activity in vitro. Curr Biol 8(3):177–180PubMedCrossRefGoogle Scholar
  15. 15.
    Metro G, Crinò L (2012) Advances on EGFR mutation for lung cancer. Transl Lung Cancer Res 1(1):5–13Google Scholar
  16. 16.
    Ge LH, Shao WL, Zhang YD et al (2011) RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells. Oncol Lett 2(6):1121–1129PubMedGoogle Scholar
  17. 17.
    Ge L, Deng Z, Zhang Y, Shao W, Qiu Y, Cui D, Huang D (2011) Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells. Oncol Rep 26(6):1487–1495PubMedGoogle Scholar
  18. 18.
    Baczyk D, Drewlo S, Proctor L, Dunk C, Lye S, Kingdom J (2009) Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 16(5):719–727PubMedCrossRefGoogle Scholar
  19. 19.
    Zielske SP, Stevenson M (2005) Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J Virol 79(17):11541–11546PubMedCrossRefGoogle Scholar
  20. 20.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408PubMedCrossRefGoogle Scholar
  21. 21.
    Folini M, Brambilla C, Villa R, Gandellini P, Vignati S, Paduano F, Daidone MG, Zaffaroni N (2005) Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. Eur J Cancer 41(4):624–634PubMedCrossRefGoogle Scholar
  22. 22.
    Hsu FM, Zhang S, Chen BP (2012) Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment. Transl Cancer Res 1(1):22–34PubMedGoogle Scholar
  23. 23.
    Blasco MA, Funk W, Villeponteau B, Greider CW (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269(5228):1267–1270PubMedCrossRefGoogle Scholar
  24. 24.
    Lin PC, Lin SZ, Chen YL, Chang JS, Ho LI, Liu PY, Chang LF, Harn YC, Chen SP, Sun LY, Huang PC, Chein JT, Tsai CH, Chou CW, Harn HJ, Chiou TW (2011) Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. Ann Surg Oncol 18(12):3514–3527PubMedCrossRefGoogle Scholar
  25. 25.
    Yegorov YE, Chernov DN, Akimov SS, Bolsheva NL, Krayevsky AA, Zelenin AV (1996) Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEBS Lett 389(2):115–118PubMedCrossRefGoogle Scholar
  26. 26.
    Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011) Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients. Clin Cancer Res 17(13):4568–4580PubMedCrossRefGoogle Scholar
  27. 27.
    Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5(10):1164–1170PubMedCrossRefGoogle Scholar
  28. 28.
    Zhang X, Mar V, Zhou W, Harrington L, Robinson MO (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13(18):2388–2399PubMedCrossRefGoogle Scholar
  29. 29.
    Xiong J, Sun WJ, Wang WF, Liao ZK, Zhou FX, Kong HY, Xu Y, Xie CH, Zhou YF (2012) Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer. Cancer 118(2):536–548PubMedCrossRefGoogle Scholar
  30. 30.
    Fujiwara T (2011) A novel molecular therapy using bioengineered adenovirus for human gastrointestinal cancer. Acta Med Okayama 65(3):151–162PubMedGoogle Scholar
  31. 31.
    Wang HB, Wang WQ, Wang XW, Sun YG, Zhou G, Yang SM, Fan DC (2011) PinX1 gene transfection enhances the sensitivity of gastric carcinoma cell line to 5-fluorouracil. Hepatogastroenterology 58(106):682–686PubMedGoogle Scholar
  32. 32.
    Uziel O, Beery E, Dronichev V, Samocha K, Gryaznov S, Weiss L, Slavin S, Kushnir M, Nordenberg Y, Rabinowitz C, Rinkevich B, Zehavi T, Lahav M (2010) Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms. PLoS ONE 5(2):e9132PubMedCrossRefGoogle Scholar
  33. 33.
    Svoboda P (2007) Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 9(3):248–257PubMedGoogle Scholar
  34. 34.
    Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806–811PubMedCrossRefGoogle Scholar
  35. 35.
    Hannon GJ (2002) RNA interference. Nature 418(6894):244–251PubMedCrossRefGoogle Scholar
  36. 36.
    Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305(5689):1437–1441PubMedCrossRefGoogle Scholar
  37. 37.
    Shadfan M, Lopez-Pajares V, Yuan ZM (2012) MDM2 and MDMX: alone and together in regulation of p53. Transl Cancer Res 1(2):88–99PubMedGoogle Scholar
  38. 38.
    Cao Y, Li H, Deb S, Liu JP (2002) TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21(20):3130–3138PubMedCrossRefGoogle Scholar
  39. 39.
    Pallini R, Sorrentino A, Pierconti F, Maggiano N, Faggi R, Montano N, Maira G, Larocca LM, Levi A, Falchetti ML (2006) Telomerase inhibition by stable RNA interference impairs tumor growth and angiogenesis in glioblastoma xenografts. Int J Cancer 118(9):2158–2167PubMedCrossRefGoogle Scholar
  40. 40.
    Curran AJ, Gullane PJ, Irish J, Macmillan C, Freeman J, Kamel-Reid S (2000) Telomerase activity is upregulated in laryngeal squamous cell carcinoma. Laryngoscope 110(3 Pt 1):391–396PubMedCrossRefGoogle Scholar
  41. 41.
    Blackburn EH (2000) Telomere states and cell fates. Nature 408(6808):53–56PubMedCrossRefGoogle Scholar
  42. 42.
    Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP (2003) TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J. 17(6):767–769PubMedGoogle Scholar
  43. 43.
    Liu JP (2000) Telomerase: not just black and white, but shades of gray. Mol Cell Biol Res Commun 3(3):129–135PubMedCrossRefGoogle Scholar
  44. 44.
    Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ, Ségal-Bendirdjian E (2006) Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119(Pt 13):2797–2806PubMedCrossRefGoogle Scholar
  45. 45.
    Lu L, Zhang C, Zhu G, Irwin M, Risch H, Menato G, Mitidieri M, Katsaros D, Yu H (2011) Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res 13(3):R56PubMedCrossRefGoogle Scholar
  46. 46.
    Wong VC, Ma J, Hawkins CE (2009) Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas. Cancer Lett 274(1):151–159PubMedCrossRefGoogle Scholar
  47. 47.
    Serrano D, Bleau AM, Fernandez-Garcia I, Fernandez-Marcelo T, Iniesta P, Ortiz-de-Solorzano C, Calvo A (2011) Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer. Mol Cancer. 10:96PubMedCrossRefGoogle Scholar
  48. 48.
    Luo Y, Yi Y, Yao Z (2009) Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells. Cancer Invest 27(10):960–970PubMedCrossRefGoogle Scholar
  49. 49.
    Chiu WT, Shen SC, Yang LY, Chow JM, Wu CY, Chen YC (2011) Inhibition of HSP90-dependent telomerase activity in amyloid β-induced apoptosis of cerebral endothelial cells. J Cell Physiol 226(8):2041–2051PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Haibo Tang
    • 1
    • 2
  • Linhu Ge
    • 1
    • 2
  • Wenlong Shao
    • 1
    • 2
  • Yuan Qiu
    • 1
    • 2
  • Dong Cui
    • 1
    • 2
  1. 1.Department of Cardiothoracic SurgeryThe First Affiliated Hospital of Guangzhou Medical CollegeGuangzhouPeople’s Republic of China
  2. 2.Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory DiseaseGuangzhouPeople’s Republic of China

Personalised recommendations